67693-58-7Relevant academic research and scientific papers
PROSTANOIDS. V. THE ω-CHAIN FOR 16-ARYLOXYTETRANORPROSTAGLANDINS
Tolstikov, G. A.,Miftakhov, M. S.,Danilova, N. A.,Galin, F. Z.
, p. 1624 - 1631 (2007/10/02)
During hydrostannylation of 4-aryloxy-3-hydroxy-1-butynes and subsequent cleavage of the obtained E-vinylstannates with iodine the corresponding E-1-iodo-3-hydroxy-4-aryloxy-1-butenes were synthesized.
1-Hydroxymethyl-1-1-oxo prostane derivatives of the E and F series
-
, (2008/06/13)
The invention disclosed herein relates to pharmacologically active prostaglandin derivatives of the E, F, or A series having on the terminal methylene carbon of the alpha chain a substituent selected from the group consisting of: STR1 wherein R is an alkyl group and R15 is C1 -C4 alkyl, C1 -C4 alkoxy, di-C1 -C4 -alkylamino, and phenyl orphenyl substituted with one or more substituents selected from the group consisting of C1 -C4 alkyl, OR, SR, F, or Cl wherein R is as previously defined.
1-Substituted-1-oxo-prostane-derivatives of the E, A and F series
-
, (2008/06/13)
The invention disclosed herein relates to pharmacologically active prostaglandin derivatives of the E, F, or A series having on the terminal methylene carbon of the alpha chain, a substituent selected from the group consisting of: STR1 wherein R is C1 to C6 alkyl, and phenyl or phenyl substituted with one or more substituents selected from the group consisting of C1 -C4 alkyl, OR16, SR16, F, or Cl, and R16 is C1 to C6 alkyl.
11-(2-Hydroxyethylthio) prostenoic acid E and F series derivatives
-
, (2008/06/13)
This disclosure describes certain 11-(2-hydroxyethylthio) prostenoic acid E and F series derivatives, and their intermediates, useful as bronchodilators and inflammatory medeator release inhibitors.
1-Hydroxymethyl-1-oxo-prostane derivatives of the E2 series
-
, (2008/06/13)
Derivatives, analogs, and congeners of prostane having a 1-(hydroxymethyl)-1-oxo-prostane structure in the E2 series.
11-(2-Hydroxyethylthio)prostenoic acid E2 series derivatives
-
, (2008/06/13)
This disclosure describes certain 11-(2-hydroxyethylthio)-9-keto-prostenoic acid E series derivatives, and their intermediates, useful as bronchodilators and inflammatory medeator release inhibitors.
